• miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study 

      Thor, Anna; Myklebust, Mette Pernille; Bergdahl, Anna Grenabo; Lundgren, Per-Olof; Skokic, Viktor; Almås, Bjarte; Haugnes, Hege Sagstuen; Tandstad, Torgrim; Akre, Olof; Cohn-Cedermark, Gabriella; Dahl, Olav; Kjellman, Anders (Journal article; Tidsskriftartikkel; Peer reviewed, 2024-11-01)
      Purpose: The SWENOTECA-MIR prospective multicenter study aims to assess the clinical value of miR-371a-3p as a novel marker in metastatic germ cell tumor patients undergoing retroperitoneal lymph node dissection (RPLND), to predict the presence of viable residual tumor.<p> <p>Materials and Methods: A total of 114 patients (86 nonseminomas, 28 seminomas) who underwent surgery for presumed metastatic ...